Amgen Inc. (AMGN) stock is trading at $438.43, up 3.17% on the day. The stock sits above its short-, medium-, and long-term moving averages, reflecting bullish ...
Amgen Inc. (AMGN) surged 3.36% after increasing investor interest on late-stage clinical trial success and strong institutional activity drove fresh demand. The move is supported by persistent ...
Amgen Inc. (AMGN) stock is trading at $407.42, gaining 3.5% on the day. The price is positioned above its key moving averages, reflecting continued strength in recent ...
Amgen announced that a Phase 3 study of its investigational therapy for patients with moderate-to-severe Sjogren’s disease activity reached its primary endpoint on September 7, 2026. Separately, ...
Amgen (AMGN) stock is trading at $397.01, marking a decline of 9.19% on the day. The price sits below its key moving averages, indicating continued short-term selling ...
Amgen announced on August 21, 2026, that a Phase 3 trial evaluating its DLL3-targeting therapy as part of first-line maintenance for extensive-stage small cell lung cancer met its primary ...
Amgen Inc. (AMGN) stock is trading at $442.51, posting a strong daily gain of 4.02%. The price is positioned above its key short- and long-term moving averages, ...
Amgen Inc. (AMGN) stock is trading at $413.76, up 4.72% on the day. The price is holding well above its key moving averages and near the session high, with firm intraday ...
Amgen is set to report its second-quarter 2026 financial results tomorrow, the company said. At the same time, Amgen stock is down 1.6% on the day at $378.89.Amgen, through its official account, ...
Amgen will report its Q2 2026 financial results on Tuesday, according to Amgen.The company posted a link for further details. The stock trades under the ticker AMGN.[highlights-block]Bullish ...
Amgen said it received a positive opinion today from the EMA's Committee for Medicinal Products for Human Use as an important step towards expanding treatment options for adults at high ...
Amgen Inc. (AMGN) stock is trading at $392.5 after rising 4.36% today. The price is above its key short- and medium-term moving averages, confirming a strong position ...
Amgen appears in MrBeast's newest video, the company said in a tweet.The video showcases Amgen, MrBeast, Stand Up To Cancer, and partners working to bring attention to the need for pediatric ...
Amgen expressed appreciation to the U.S. Department of Health and Human Services for organizing a Clinical Trials Roundtable.The company said clinical trials are key to bringing new medicines to ...
Amgen is investing more than $1.5 billion in North Carolina's life sciences ecosystem, the company said on social media.Amgen says the investment contributes to innovation, growth, and opportunity ...
Amgen Inc. (AMGN) stock is trading at $349.04, up 3.35% today. The price currently sits above its key moving averages, reflecting momentum in the current ...
Amgen shared new data on cardiometabolic care at the #ADASciSessions 2026, the company said in a tweet.Amgen said the data reinforce the need for more integrated approaches to prevention, risk ...
Amgen CEO Bob Bradway appeared on Bain and Company's Winning with AI podcast alongside Sarah Elk and AI pioneer Andrew Ng, the company said in a tweet.The discussion covered how AI is accelerating ...
Amgen Inc. (AMGN) stock is trading at $338.42, up 3.09% today. The price currently sits above its short- and long-term moving averages, indicating support from these ...
Amgen announced the presentation of new data across rare autoimmune and inflammatory diseases at EULAR2026.The research covers IgG4-related disease and real-world evidence in ANCA-associated ...
Amgen Inc. (AMGN) is trading at $329.33, representing a daily decline of $7.56 or 2.24%. The asset remains just above its 200-day simple moving average ($328.23), while positioned below both the ...